𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration

✍ Scribed by Roberto Maisano; Pietro Spadaro; Giuseppe Toscano; Nicola Caristi; Stefano Pergolizzi; Vincenzino Salimbeni

Book ID
106174751
Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
110 KB
Volume
9
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A study evaluating the efficacy and tole
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
✍ Bengt G. Sorbe; Anne-Marie Berglind; Håkan Andersson; Karin Boman; Thomas Högber 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

## BACKGROUND. Chemotherapy-induced emesis is one of the most disturbing side effects of cancer therapy. Control of acute emesis has improved substantially during recent years, but control of delayed emesis and nausea remains a challenging problem. The role of 5-HT3 receptor antagonists in the tre

Prevention of cisplatin-induced acute an
Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 : A randomized controlled trial
✍ Simon Van Belle; Michael R. Lichinitser; Rudolph M. Navari; August M. Garin; Mar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract ## BACKGROUND Recent studies have suggested that antiemetic therapy with a triple combination of the neurokinin‐1 receptor antagonist MK‐869, a serotonin (5‐HT~3~) antagonist, and dexamethasone provides enhanced control of cisplatin‐induced emesis compared with standard therapy regimen